Swedish Orphan Biovitrum AB (publ) (OTCPK:BIOVF) Q1 2020 Earnings Conference Call April 29, 2020 7:00 AM ET
Company Participants
Guido Oelkers - Chief Executive Officer
Henrik Stenqvist - Chief Financial Officer
Milan Zdravkovic - Head-Research and Development
Conference Call Participants
Eun Yang - Jefferies
Christopher Uhde - SEB
Peter Sehested - Handelsbanken
Johan Unnerus - Pareto Securities
Viktor Sundberg - ABG
Brian Balchin - Barclays
Guido Oelkers
Yes. Welcome everybody. It's really a great pleasure to have you here on the Sobi call knowing that we are competing this quite another -- quite a few other earnings calls. So I go right into it. We'll start with the forward looking statement as per usual, and please take not of this. And then I come to the presenters of today, this is Henrik, our CFO and Milan, our Head of R&D, who will join me for this call.
And with this having said, these are obviously unprecedented times, so I go to slide number four, and very challenging times. So before we talk about our very significant top line and -- top and bottom line growth, just wanted to tell you that we the absolutely take this situation very seriously and take charge.
So for us the first priority was to make sure that patients requiring any of our products get access and we have achieved this. So we made sure that the supply chain has been ramped up in view of this new situation. For us, it was also important to make sure that our team is protected and we took the right measure in the early stage in terms of virtuality of our office environment and also travel restrictions.
But we also want to make sure that we are staying in contact with our HCPs in the proper way
- Read more current BIOVF analysis and news
- View all earnings call transcripts